12. S. Phuphanich et al. , Phase I trial of a multi- epitope -pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer immunology, immunotherapy : CII 62, 125 -135 (2013). 13. Y. Akiyama et al. , alpha -type -1 polarized dendritic cell- based vaccination in recurrent high -grade glioma: a phase I clinical trial. BMC cancer 12, 623 (2012). 14. A. Bender, M. Sapp, G. Schuler, R. M. Steinman, N. Bhardwaj, Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. Journal of immunological methods 196, 121 -135 (1996). 15. J. M. Timmerman, R. Levy, Dendritic cell vaccines for cancer immunotherapy. Annual review of medicine 50, 507 -529 (1999). 16. M. Chiriva-Internati et al. , Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Blood 100, 961 -965 (2002). 17. D. Ridgway, The first 1000 dendritic cell vaccinees. Cancer investigation 21, 873 -886 (2003). 18. W. K. Bae, A. Umeyama, I. J. Chung, J. J.